Breathe Well Live Well
|
Array's asthma drug posts good results
Boulder County Business Report Ron Squarer, chief executive of Array, noted, "With many asthma patients poorly controlled on currently available therapies, a drug targeting a novel, nonoverlapping mechanism may present an important new option for millions of patients. We are seeking … |
View full post on asthma – Google News
|
Array asthma drug posts good results
Boulder County Business Report Ron Squarer, chief executive of Array, noted, "With many asthma patients poorly controlled on currently available therapies, a drug targeting a novel, nonoverlapping mechanism may present an important new option for millions of patients. We are seeking … |
View full post on asthma – Google News
|
Shares jump as Array BioPharma reports positive results for asthma drug
The Pharma Letter US biotech firm Array BioPharma (Nasdaq: ARRY) saw its shares jump as it announced that its drug candidate for mild to moderate persistent allergic asthma, ARRY-502, an oral CRTh2 antagonist, met all primary and secondary endpoints. The company said … |
View full post on asthma – Google News
|
Array Seeks Asthma Drug Partner Following Mid-Stage Study Results
TheStreet.com BOULDER, Col. (TheStreet) — An experimental pill from Array BioPharma (ARRY) improved lung function in patients who suffer from asthma brought on by allergies, according to results from a small mid-stage study announced Tuesday. Array shares rose 15 … |
View full post on asthma – Google News
|
Array Biopharma To Report Top-line Results From ARRY-502 Asthma Trial
Benzinga Array BioPharma Inc. (Nasdaq: ARRY) will report top-line results from a placebo-controlled, randomized, double?blind Phase 2 trial in mild to moderate persistent allergic asthma for ARRY-502, an oral CRTh2 antagonist and hold a conference call to … |
View full post on asthma – Google News
|
Exposed: Edward Erin, the doctor whose faked asthma drug test results proved …
The Independent From 2004 to 2006, three-quarters of 309 patients with severe and uncontrolled asthma who had volunteered to take part were given the drug, known as Golimumab, in three different strengths; the rest were on placebos. Dr Sally Wenzel, professor of … |
View full post on asthma – Google News
|
Boehringer Ingelheim's tiotropium shows promising results in patients with …
News-Medical.net Boehringer Ingelheim today announced data from Phase 2 and Phase 3 studies from the Company's ongoing clinical trial program investigating the efficacy and safety of tiotropium in asthma. These data were presented at the American Thoracic Society … Phase III results: tiotropium* Respimat® effective in symptomatic asthma … Boehringer Ingelheim reports positive data from symptomatic asthma trials |
View full post on asthma – Google News
|
Treatment for Adults with Asthma Yield Positive Results
WBBJ-TV Many West Tennesseans who suffer from asthma are getting some relief thanks to a new procedure, called bronchial thermoplatsy. The non-drug procedure that can reduce severe asthma symptoms for people 18 and older. Doctors hope this treatment can … |
View full post on asthma – Google News
|
Cytos Biotechnology soars on results of asthma-drug study
FierceBiotech After closing out a failed Novartis partnership in January, Cytos Biotechnology has registered some upbeat data from a mid-stage study of its lead drug against allergic asthma. On the news, Zurich-based Cytos' shares jumped 14% as of early this morning … Cytos Rises After Asthma Drug Succeeds in Trial: Zurich Mover The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study … |
View full post on asthma – Google News
|
Phase III results: tiotropium* Respimat® is effective in symptomatic asthma …
Business Wire (press release) SAN ANTONIO, Texas–(BUSINESS WIRE)–Tiotropium delivered once daily via Respimat™ significantly improved lung function and reduced asthma exacerbations in patients who remain symptomatic despite treatment with at least ICS†/LABA‡, irrespective … Boehringer Ingelheim Presents Efficacy Data for Tiotropium in Symptomatic … |
View full post on asthma – Google News